Michael Mor
Tel Aviv, TA 69978, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 25, 2026
Author Correction: Pulmonary diffusing capacity among individuals recovering from mild to moderate COVID-19: a cross-sectional study.
Journal: Scientific reports
Published: December 17, 2024
Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 21, 2024
β2-adrenergic signaling promotes higher-affinity B cells and antibodies.
Journal: Brain, behavior, and immunity
Published: March 16, 2023
Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens.
Journal: iScience
Published: October 31, 2022
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics.
Journal: JCI insight
Published: October 24, 2022
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.
Journal: Communications biology
Published: February 17, 2022
Tumor-reactive antibodies evolve from non-binding and autoreactive precursors.
Journal: Cell
Published: May 13, 2021
Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors.
Journal: bioRxiv : the preprint server for biology
Published: October 14, 2020
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.
Journal: PLoS pathogens
Published: September 30, 2020
Last Updated: 09/26/2026